Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II

Touraine, 1978, Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens, J. Pediatr., 93, 47, 10.1016/S0022-3476(78)80598-8

Reith, 2014, Molecular basis of major histocompatibility complex class II deficiency, 241

Masternak, 2000, Molecular genetics of the bare lymphocyte syndrome, Rev. Immunogenet., 2, 267

Bousfiha, 2018, The 2017 IUIS phenotypic classification for primary immunodeficiencies, J. Clin. Immunol., 38, 129, 10.1007/s10875-017-0465-8

Ouederni, 2011, Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients, Blood, 118, 5108, 10.1182/blood-2011-05-352716

Castano-Jaramillo, 2020, Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency, Pediatr. Transplant., 24, 10.1111/petr.13774

Brown, 2011, Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening, Blood, 117, 3243, 10.1182/blood-2010-08-300384

Storek, 2008, Reconstitution of the immune system after hematopoietic stem cell transplantation in humans, Semin. Immunopathol., 30, 425, 10.1007/s00281-008-0132-5

Bosch, 2012, Immune reconstitution after hematopoietic cell transplantation, Curr. Opin. Hematol., 19, 324, 10.1097/MOH.0b013e328353bc7d

Pai, 2014, Transplantation outcomes for severe combined immunodeficiency, 2000-2009, N. Engl. J. Med., 371, 434, 10.1056/NEJMoa1401177

van der Burg, 2019, The EuroFlow PID orientation tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system, Front. Immunol., 10, 246, 10.3389/fimmu.2019.00246

Kalina, 2020, EuroFlow standardized approach to diagnostic immunopheneotyping of severe PID in newborns and young children, Front. Immunol., 11, 10.3389/fimmu.2020.00371

King, 2018, Newborn screening for primary immunodeficiency diseases: history, current and future practice, J. Clin. Immunol., 38, 56, 10.1007/s10875-017-0455-x

Blom, 2018, Introducing newborn screening for severe combined immunodeficiency (SCID) in the Dutch neonatal screening program, Int. J. Neonatal. Screen., 4, 40, 10.3390/ijns4040040

Blom, 2021, Parents’ perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands, J. Clin. Immunol., 41, 99, 10.1007/s10875-020-00886-4

Kuo, 2013, Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome, J. Allergy Clin. Immunol., 131, 1693, 10.1016/j.jaci.2013.01.019

Roifman, 2012, Defining combined immunodeficiency, J. Allergy Clin. Immunol., 130, 177, 10.1016/j.jaci.2012.04.029

Lum, 2020, Improved transplant survival and long-term disease outcome in children with MHC class II deficiency, Blood, 135, 954, 10.1182/blood.2019002690

Reith, 2005, Regulation of MHC class II gene expression by the class II transactivator, Nat. Rev. Immunol., 5, 793, 10.1038/nri1708

Gyurkocza, 2014, Conditioning regimens for hematopoietic cell transplantation: one size does not fit all, Blood, 124, 344, 10.1182/blood-2014-02-514778

Admiraal, 2015, Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis, Lancet Haematol., 2, 194, 10.1016/S2352-3026(15)00045-9

Hoare, 2017, Predicting CD4 T-cell reconstitution following pediatric hematopoietic stem cell transplantation, Clin. Pharmacol. Ther., 102, 349, 10.1002/cpt.621

Damoiseaux, 2020, The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor, Clin. Immunol., 218, 10.1016/j.clim.2020.108515

Homma, 1997, Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation, Transplant. Proc., 29, 1743, 10.1016/S0041-1345(97)00039-0

Damoiseaux, 1997, Multiple effects of cyclosporin A on the thymus in relation to T-cell development and autoimmunity, Clin. Immunol. Immunopathol., 82, 197, 10.1006/clin.1996.4254

Damoiseaux, 1996, Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat, Transplantation., 62, 994, 10.1097/00007890-199610150-00019

Damoiseaux, 2002, Cyclosporin A-induced autoimmunity in the rat: central versus peripheral tolerance, Int. J. Immunopathol. Pharmacol., 15, 81, 10.1177/039463200201500202

Truffault, 2017, Thymic germinal centers and corticosteroids in myasthenia gravis: an Immunopathological study in 1035 cases and a critical review, Clin. Rev. Allergy Immunol., 52, 108, 10.1007/s12016-016-8558-3